Announced
Completed
Synopsis
Vivo Capital, a global healthcare investment firm, completed its investment in Seran BioScience, a manufacturing firm providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Financial terms were not disclosed. "Seran has built an exceptional organization that is predicated on technical excellence, science-driven decision-making, and an unwavering commitment to quality and customer service. Seran's specialized expertise in enhanced solubility and engineered particle formulations enables solutions to some of the most difficult challenges in drug development. We look forward to supporting founders Dan and John in the journey ahead," Mahendra Shah, Vivo Managing Director.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.